RICERCA
AUTORI
RIVISTE
Sfoglia per RIVISTA
LEUKEMIA
Collezione AOU Novara
Items : 21
Second versus first wave of COVID-19 in patients with MPN. in Leukemia / Leukemia. 2022 Mar;36(3):897-900. doi: 10.1038/s41375-022-01507-2. Epub 2022 Jan 21.
2022
AOU Città della Salute di Torino
AOU Novara
AO Alessandria
Quiroz Cervantes K; Benevolo G; Vannucchi AM; Carobbio A; Ghirardi A; Carioli G; Sobas MA; Elli EM; Rumi E; De Stefano V; Curto-Garcia N; Benajiba L; Bellini M; Rambaldi A; Cavalca F; Borsani O; Betti S; Masternak Kulikowska de Na??cz A; Bucelli C; Cichocka E; Cattaneo D; Koschmieder S; Lopez Abadia E; Angona A; Xicoy Cirici B; Navas Elorza B; Kusec R; Sagues Serrano M; Osorio S; et alii...
Outcomes in first relapsed-refractory younger patients with mantle cell lymphoma: results from the MANTLE-FIRST study. in Leukemia / Leukemia. 2021 Mar;35(3):787-795. doi: 10.1038/s41375-020-01013-3. Epub 2020 Aug 11.
2021
AOU Città della Salute di Torino
AOU Novara
Balzarotti M; Vitolo U; Krampera M; Rule S; Petrucci L; Arcaini L; Sica A; Celis MIA; Ferrero S; Fabbri A; Polli V; Bozzoli V; Cox MC; Stefani PM; Pennese E; Perrone T; Nassi L; Gini G; McCulloch R; Marin-Niebla A; Chiappella A; Tecchio C; Sciarra R; Re A; Rusconi C; Hohaus S; Tisi MC; Morello L; Zilioli VR; et alii...
Correction: Outcomes in first relapsed-refractory younger patients with mantle cell lymphoma: results from the MANTLE-FIRST study. in Leukemia / Leukemia. 2021 Mar;35(3):932. doi: 10.1038/s41375-020-01119-8.
2021
AOU Città della Salute di Torino
AOU Novara
Balzarotti M; Vitolo U; Krampera M; Arcaini L; Rule S; Petrucci L; Sica A; Ferrero S; De Celis MIA; Fabbri A; Polli V; Cox MC; Bozzoli V; Pennese E; Stefani PM; Gini G; Perrone T; Nassi L; McCulloch R; Chiappella A; Marin-Niebla A; Tecchio C; Sciarra R; Re A; Rusconi C; Hohaus S; Morello L; Quaglia FM; Zilioli VR; et alii...
Survival risk score for real-life relapsed/refractory chronic lymphocytic leukemia patients receiving ibrutinib. A campus CLL study. in Leukemia / Leukemia. 2021 Jan;35(1):235-238. doi: 10.1038/s41375-020-0833-x. Epub 2020 Apr 14.
2021
AO Cuneo
AOU Città della Salute di Torino
AO Alessandria
AOU Novara
Sportoletti P; Laurenti L; Gattei V; Gaidano G; Polliack A; Foà R; Rossi D; Cuneo A; Di Raimondo F; Rigolin GM; Bomben R; Biagi A; Del Giudice I; Angeletti I; Rago A; Arrigo G; Vigna E; Botta C; Tripepi G; Fraticelli V; Zucchetto A; Scortechini I; Loseto G; Consoli U; Rossi FM; Pietrasanta D; Murru R; Chiarenza A; Condoluci A; et alii...
High mortality rate in COVID-19 patients with myeloproliferative neoplasms after abrupt withdrawal of ruxolitinib. in Leukemia / Leukemia. 2021 Feb;35(2):485-493. doi: 10.1038/s41375-020-01107-y. Epub 2021 Jan 7.
2021
AOU Città della Salute di Torino
AOU Novara
Betti S; Harrison C; De Stefano V; Bellini M; Bellosillo B; Benajiba L; Curto-Garcia N; Daffini R; Cavalca F; Cattaneo D; Garrote M; Cirici BX; Guglielmelli P; Abadia EL; Hernandez-Boluda JC; Cuevas B; Ruggeri M; Koschmieder S; Mazo EM; Angona A; Elorza BN; Patriarca A; Carreno-Tarragona G; Sobas MA; Lunghi F; Papadopoulos P; Bonifacio M; Cervantes KSQ; Serrano MS; et alii...
COVID-19 severity and mortality in patients with CLL: an update of the international ERIC and Campus CLL study. in Leukemia / Leukemia. 2021 Dec;35(12):3444-3454. doi: 10.1038/s41375-021-01450-8. Epub 2021 Nov 1.
2021
AO Cuneo
AOU Città della Salute di Torino
AO Alessandria
AOU Novara
Ghia P; Stamatopoulos K; Cuneo A; Montserrat E; Foà R; Yassin M; Coscia M; Rambaldi A; San Segundo LY; Visentin A; Vitale C; Wasik-Szczepanek E; Wróbel T; van Kampen R; Varettoni M; Tadmor T; Te Raa D; Tonino SH; van Gelder M; Van Der Spek E; Trentin L; Sportoletti P; Stanca O; Stavroyianni N; Špa?ek M; Šimkovi? M; Shrestha A; Saghumyan G; Ruchlemer R; et alii...
Impact of somatic mutations in myelodysplastic patients with isolated partial or total loss of chromosome 7. in Leukemia / Leukemia. 2020 Sep;34(9):2441-2450. doi: 10.1038/s41375-020-0728-x. Epub 2020 Feb 17.
2020
AOU Città della Salute di Torino
AOU Novara
Santini V; Martínez ABV; Hildebrandt B; Germing U; Ferrero D; Lea N; Cervera J; Kizilors A; Mian SA; Best S; Shirneshan K; Haase D; Schanz J; Such E; Adema V; Kulasekararaj AG; Crisà E; Sanz GF; Solé F; Mufti GJ;
The IPSS-R more accurately captures fatigue severity of newly diagnosed patients with myelodysplastic syndromes compared with the IPSS index. in Leukemia / Leukemia. 2020 Sep;34(9):2451-2459. doi: 10.1038/s41375-020-0746-8. Epub 2020 Feb 21.
2020
AOU Città della Salute di Torino
AOU Novara
Capodanno I; Frairia C; Fianchi L; Luppi M; Petranovic D; Caers J; Ricco A; Stauder R; Caocci G; Palumbo GA; Platzbecker U; Breccia M; Niscola P; Patriarca A; Cella D; Oswald LB; Cottone F; Efficace F; Follini E; Sarlo C; Fazi P; Vignetti M;
COVID-19 severity and mortality in patients with chronic lymphocytic leukemia: a joint study by ERIC, the European Research Initiative on CLL, and CLL Campus. in Leukemia / Leukemia. 2020 Sep;34(9):2354-2363. doi: 10.1038/s41375-020-0959-x. Epub 2020 Jul 9.
2020
AO Cuneo
AOU Città della Salute di Torino
AO Alessandria
AOU Novara
Foà R; Rambaldi A; Montserrat E; Rossi G; Stamatopoulos K; Coscia M; Stavroyianni N; Strugov V; Tam C; Zdrenghea M; Shah N; Shrestha A; Stanca O; Ortiz Pareja M; Papaioannou M; Rossi D; Kalashnikova O; Hakobyan Y; Doubek M; Enrico A; Dimou M; Andres M; Chiarenza A; Nikitin E; Dos Santos G; Barna G; Yassin M; Pocali B; Sportoletti P; et alii...
Correction: Bidirectional linkage between the B-cell receptor and NOTCH1 in chronic lymphocytic leukemia and in Richter's syndrome: therapeutic implications. in Leukemia / Leukemia. 2020 Jun;34(6):1721. doi: 10.1038/s41375-019-0680-9.
2020
AOU Città della Salute di Torino
AOU Novara
Packham G; Furman RR; Allan JN; Gaidano G; D'Arena G; Coscia M; Yeomans A; Gizzi K; Vaisitti T; Vitale N; Bracciamà V; Arruga F; Forconi F; Deaglio S;
Health-related quality of life of newly diagnosed chronic myeloid leukemia patients treated with first-line dasatinib versus imatinib therapy. in Leukemia / Leukemia. 2020 Feb;34(2):488-498. doi: 10.1038/s41375-019-0563-0. Epub 2019 Sep 2.
2020
AOU Città della Salute di Torino
AOU Novara
Rosti G; Binotto G; Vignetti M; Bergamaschi M; Fozza C; Cascavilla N; Saussele S; Pregno P; Gozzini A; Patriarca A; Capodanno I; Martino B; Tiribelli M; Crugnola M; Caocci G; Castagnetti F; Abruzzese E; Cottone F; Bonifacio M; Breccia M; Iurlo A; Efficace F; Stagno F;
Bidirectional linkage between the B-cell receptor and NOTCH1 in chronic lymphocytic leukemia and in Richter's syndrome: therapeutic implications. in Leukemia / Leukemia. 2020 Feb;34(2):462-477. doi: 10.1038/s41375-019-0571-0. Epub 2019 Aug 29.
2020
AOU Città della Salute di Torino
AOU Novara
Deaglio S; Packham G; Forconi F; Furman RR; Allan JN; Gaidano G; D'Arena G; Coscia M; Gizzi K; Yeomans A; Vaisitti T; Vitale N; Bracciamà V; Arruga F;
A phase II, multicentre trial of decitabine in higher-risk chronic myelomonocytic leukemia. in Leukemia / Leukemia. 2018 Feb;32(2):413-418. doi: 10.1038/leu.2017.186. Epub 2017 Jun 13.
2018
AOU Città della Salute di Torino
AOU Novara
Onida F; Finelli C; Angelucci E; Terenzi A; Abdel-Wahab O; Ceccarelli M; Masiera E; Sanna A; Cilloni D; Lunghi M; Poloni A; Gioia D; Zini G; Allione B; Santini V; Pelizzari A; Ferrero D; Saglio G; Figueroa M; Levis A;
Once-weekly carfilzomib, pomalidomide, and low-dose dexamethasone for relapsed/refractory myeloma: a phase I/II study. in Leukemia / Leukemia. 2018 Aug;32(8):1803-1807. doi: 10.1038/s41375-018-0024-1. Epub 2018 Jan 30.
2018
AOU Città della Salute di Torino
AOU Novara
Palumbo A; Lombardo A; Bertazzoni P; Rossi G; De Paoli L; Fanin R; Troia R; Patriarca F; Gaidano G; Belotti A; Spada S; Liberati AM; Cafro AM; Mina R; Bringhen S; Sonneveld P; Boccadoro M;
Validation of a biological score to predict response in chronic lymphocytic leukemia patients treated front-line with bendamustine and rituximab. in Leukemia / Leukemia. 2018 Aug;32(8):1869-1873. doi: 10.1038/s41375-018-0100-6. Epub 2018 Mar 20.
2018
AOU Città della Salute di Torino
AOU Novara
Gaidano G; Del Poeta G; Cortelezzi A; Tadmor T; Shvidel L; Herishanu Y; Recchia AG; Vigna E; D'Arrigo G; Tripepi G; Innocenti I; Uccello G; Parikh SA; Chaffee KG; Cutrona G; Giordano A; Chiarenza A; Coscia M; Angrilli F; Molica S; Di Renzo N; Rossi D; Del Principe MI; Laurenti L; Ciolli S; Zirlik K; Mauro FR; Reda G; Shanafelt TD; et alii...
Phase 1/2 study of weekly carfilzomib, cyclophosphamide, dexamethasone in newly diagnosed transplant-ineligible myeloma. in Leukemia / Leukemia. 2018 Apr;32(4):979-985. doi: 10.1038/leu.2017.327. Epub 2017 Nov 16.
2018
AOU Città della Salute di Torino
AOU Novara
Palumbo A; Corradini P; Gaidano G; Petrucci MT; Offidani M; Ballanti S; De Angelis C; Musto P; Esma F; Muccio VE; Grammatico S; Liberati AM; Galieni P; Montefusco V; De Paoli L; D'Agostino M; Bringhen S; Sonneveld P; Boccadoro M;
A randomized phase III study of carfilzomib vs low-dose corticosteroids with optional cyclophosphamide in relapsed and refractory multiple myeloma (FOCUS). in Leukemia / Leukemia. 2017 Jan;31(1):107-114. doi: 10.1038/leu.2016.176. Epub 2016 Jun 24.
2017
AOU Novara
Hájek R; Masszi T; Petrucci MT; Palumbo A; Rosiñol L; Nagler A; Yong KL; Oriol A; Minarik J; Pour L; Dimopoulos MA; Maisnar V; Rossi D; Kasparu H; Van Droogenbroeck J; Yehuda DB; Hardan I; Jenner M; Calbecka M; Dávid M; de la Rubia J; Drach J; Gasztonyi Z; Górnik S; Leleu X; Munder M; Offidani M; Zojer N; Rajangam K; et alii...
High rate of recurrent venous thromboembolism in patients with myeloproliferative neoplasms and effect of prophylaxis with vitamin K antagonists. in Leukemia / Leukemia. 2016 Oct;30(10):2032-2038. doi: 10.1038/leu.2016.85. Epub 2016 Apr 26.
2016
AO Cuneo
AOU Novara
Barbui T; Vannucchi AM; Sant'Antonio E; Griesshammer M; Carobbio A; Musolino C; Rapezzi D; Forcina A; Pungolino E; Specchia G; Hernandez-Boluda JC; Tieghi A; Ellis MH; Cacciola R; Palova M; Cattaneo D; Nichele I; Betti S; Rossi E; Gaidano G; Zetterberg E; Vianelli N; Finazzi G; Finazzi MC; Elli E; Randi ML; Alvarez-Larrán A; Iurlo A; Ruggeri M; et alii...
A phase 2 study of three low-dose intensity subcutaneous bortezomib regimens in elderly frail patients with untreated multiple myeloma. in Leukemia / Leukemia. 2016 Jun;30(6):1320-6. doi: 10.1038/leu.2016.36. Epub 2016 Feb 22.
2016
AOU San Luigi di Orbassano
AOU Città della Salute di Torino
AOU Novara
Conticello C; Musolino C; De Paoli L; Nozzoli C; Aghemo E; Guglielmelli T; Genuardi M; Derudas D; Ponticelli E; Carella AM; Vincelli ID; Spada S; De Rosa L; Omedé P; Passera R; Montefusco V; Liberati AM; Morabito F; Benevolo G; Villani O; Falcone AP; Caravita T; Oliva S; Petrucci MT; Bringhen S; Larocca A; Offidani M; Boccadoro M; Sonneveld P; et alii...
Circulating miRNA markers show promise as new prognosticators for multiple myeloma. in Leukemia / Leukemia. 2014 Sep;28(9):1922-6. doi: 10.1038/leu.2014.155. Epub 2014 May 12.
2014
AOU Città della Salute di Torino
AOU Novara
Boccadoro M; Byrd JC; Alder H; Magarotto V; Weiss B; Ferro A; Callea V; Bringhen S; Benevolo G; Ria R; Consiglio J; Gentili S; Uccello G; Rossi D; De Luca L; Isaia G; Omedè P; Smith EM; Dirisala V; Talabere T; Efebera YA; Benson DM; Guan J; Cascione L; Gambella M; Stiff A; Geyer S; Hofmeister CC; Rocci A; et alii...
Bendamustine in combination with ofatumumab in relapsed or refractory chronic lymphocytic leukemia: a GIMEMA Multicenter Phase II Trial. in Leukemia / Leukemia. 2014 Mar;28(3):642-8. doi: 10.1038/leu.2013.334. Epub 2013 Nov 13.
2014
AOU Città della Salute di Torino
AOU Novara
Neri A; Piciocchi A; Vignetti M; Morabito F; Fabris S; Mauro FR; Gobbi M; Cascavilla N; Angelucci E; Storti S; Orsucci L; Gritti G; Chiarenza A; Marasca R; Zaja F; Laurenti L; Reda G; Cuneo A; Vincenti D; Liberati AM; Sciumè M; Cortelezzi A; Rossi D; Giannarelli D; Guarini A; Foà R;